Header Logo

Connection

Johanna Seddon to Middle Aged

Back to Details
This is a "connection" page, showing publications Johanna Seddon has written about Middle Aged.
Johanna Seddon
Connection Strength
1.647
Middle Aged
  1. Seddon JM, De D, Grunenkovaite L, Ferrara D. Clinical and Imaging Characteristics of PRPH2 Retinopathies in a Longitudinal Cohort and Diagnostic Implications. Invest Ophthalmol Vis Sci. 2024 Dec 02; 65(14):31.
    View in: PubMed
    Score: 0.073
  2. Seddon JM, De D, Rosner B. The role of nutritional factors in transitioning between early, mid, and late stages of age-related macular degeneration: prospective longitudinal analysis. Am J Clin Nutr. 2024 Dec; 120(6):1387-1398.
    View in: PubMed
    Score: 0.071
  3. Merle BMJ, Rosner B, Seddon JM. Genetic Susceptibility, Diet Quality, and Two-Step Progression in Drusen Size. Invest Ophthalmol Vis Sci. 2020 05 11; 61(5):17.
    View in: PubMed
    Score: 0.053
  4. Seddon JM, Rosner B. Validated Prediction Models for Macular Degeneration Progression and Predictors of Visual Acuity Loss Identify High-Risk Individuals. Am J Ophthalmol. 2019 02; 198:223-261.
    View in: PubMed
    Score: 0.048
  5. Merle BMJ, Silver RE, Rosner B, Seddon JM. Associations Between Vitamin D Intake and Progression to Incident Advanced Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2017 09 01; 58(11):4569-4578.
    View in: PubMed
    Score: 0.044
  6. Seddon JM, McLeod DS, Bhutto IA, Villalonga MB, Silver RE, Wenick AS, Edwards MM, Lutty GA. Histopathological Insights Into Choroidal Vascular Loss in Clinically Documented Cases of Age-Related Macular Degeneration. JAMA Ophthalmol. 2016 Nov 01; 134(11):1272-1280.
    View in: PubMed
    Score: 0.041
  7. Seddon JM, Silver RE, Rosner B. Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis. Br J Ophthalmol. 2016 Dec; 100(12):1731-1737.
    View in: PubMed
    Score: 0.041
  8. Merle BM, Silver RE, Rosner B, Seddon JM. Dietary folate, B vitamins, genetic susceptibility and progression to advanced nonexudative age-related macular degeneration with geographic atrophy: a prospective cohort study. Am J Clin Nutr. 2016 Apr; 103(4):1135-44.
    View in: PubMed
    Score: 0.040
  9. Shah AR, Williams S, Baumal CR, Rosner B, Duker JS, Seddon JM. Predictors of Response to Intravitreal Anti-Vascular Endothelial Growth Factor Treatment of Age-Related Macular Degeneration. Am J Ophthalmol. 2016 Mar; 163:154-166.e8.
    View in: PubMed
    Score: 0.039
  10. Merle BM, Silver RE, Rosner B, Seddon JM. Adherence to a Mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: a prospective cohort study. Am J Clin Nutr. 2015 Nov; 102(5):1196-206.
    View in: PubMed
    Score: 0.039
  11. Ferrara D, Seddon JM. Phenotypic Characterization of Complement Factor H R1210C Rare Genetic Variant in Age-Related Macular Degeneration. JAMA Ophthalmol. 2015 Jul; 133(7):785-91.
    View in: PubMed
    Score: 0.038
  12. Seddon JM, Silver RE, Kwong M, Rosner B. Risk Prediction for Progression of Macular Degeneration: 10 Common and Rare Genetic Variants, Demographic, Environmental, and Macular Covariates. Invest Ophthalmol Vis Sci. 2015 Apr; 56(4):2192-202.
    View in: PubMed
    Score: 0.037
  13. Seddon JM, Reynolds R, Yu Y, Rosner B. Three new genetic loci (R1210C in CFH, variants in COL8A1 and RAD51B) are independently related to progression to advanced macular degeneration. PLoS One. 2014; 9(1):e87047.
    View in: PubMed
    Score: 0.034
  14. Seddon JM, Reynolds R, Yu Y, Rosner B. Validation of a prediction algorithm for progression to advanced macular degeneration subtypes. JAMA Ophthalmol. 2013 Apr; 131(4):448-55.
    View in: PubMed
    Score: 0.032
  15. Ioannidis JP, Yu Y, Seddon JM. Correction of phenotype misclassification based on high-discrimination genetic predictive risk models. Epidemiology. 2012 Nov; 23(6):902-9.
    View in: PubMed
    Score: 0.031
  16. Leveziel N, Yu Y, Reynolds R, Tai A, Meng W, Caillaux V, Calvas P, Rosner B, Malecaze F, Souied EH, Seddon JM. Genetic factors for choroidal neovascularization associated with high myopia. Invest Ophthalmol Vis Sci. 2012 Jul 27; 53(8):5004-9.
    View in: PubMed
    Score: 0.031
  17. Yu Y, Reynolds R, Rosner B, Daly MJ, Seddon JM. Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models. Invest Ophthalmol Vis Sci. 2012 Mar; 53(3):1548-56.
    View in: PubMed
    Score: 0.030
  18. Raychaudhuri S, Iartchouk O, Chin K, Tan PL, Tai AK, Ripke S, Gowrisankar S, Vemuri S, Montgomery K, Yu Y, Reynolds R, Zack DJ, Campochiaro B, Campochiaro P, Katsanis N, Daly MJ, Seddon JM. A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat Genet. 2011 Oct 23; 43(12):1232-6.
    View in: PubMed
    Score: 0.029
  19. Wise LA, Rosenberg L, Radin RG, Mattox C, Yang EB, Palmer JR, Seddon JM. A prospective study of diabetes, lifestyle factors, and glaucoma among African-American women. Ann Epidemiol. 2011 Jun; 21(6):430-9.
    View in: PubMed
    Score: 0.028
  20. Weiner DE, Tighiouart H, Reynolds R, Seddon JM. Kidney function, albuminuria and age-related macular degeneration in NHANES III. Nephrol Dial Transplant. 2011 Oct; 26(10):3159-65.
    View in: PubMed
    Score: 0.028
  21. Seddon JM, Reynolds R, Rosner B. Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration. Mol Vis. 2010 Nov 17; 16:2412-24.
    View in: PubMed
    Score: 0.027
  22. Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, Seddon JM. Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet. 2009 Jan; 17(1):100-4.
    View in: PubMed
    Score: 0.023
  23. Klein ML, Francis PJ, Rosner B, Reynolds R, Hamon SC, Schultz DW, Ott J, Seddon JM. CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology. 2008 Jun; 115(6):1019-25.
    View in: PubMed
    Score: 0.023
  24. Seddon JM, Francis PJ, George S, Schultz DW, Rosner B, Klein ML. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA. 2007 Apr 25; 297(16):1793-800.
    View in: PubMed
    Score: 0.021
  25. Francis PJ, George S, Schultz DW, Rosner B, Hamon S, Ott J, Weleber RG, Klein ML, Seddon JM. The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered. 2007; 63(3-4):212-8.
    View in: PubMed
    Score: 0.021
  26. Seddon JM, George S, Rosner B, Klein ML. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered. 2006; 61(3):157-65.
    View in: PubMed
    Score: 0.020
  27. Seddon JM, Gensler G, Klein ML, Milton RC. Evaluation of plasma homocysteine and risk of age-related macular degeneration. Am J Ophthalmol. 2006 Jan; 141(1):201-3.
    View in: PubMed
    Score: 0.020
  28. Seddon JM, George S, Rosner B, Rifai N. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol. 2005 Jun; 123(6):774-82.
    View in: PubMed
    Score: 0.019
  29. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA. 2004 Feb 11; 291(6):704-10.
    View in: PubMed
    Score: 0.017
  30. Seddon JM, Cote J, Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol. 2003 Dec; 121(12):1728-37.
    View in: PubMed
    Score: 0.017
  31. Seddon JM, Sharma S, Chong S, Hutchinson A, Allikmets R, Adelman RA. Phenotype and genotype correlations in two best families. Ophthalmology. 2003 Sep; 110(9):1724-31.
    View in: PubMed
    Score: 0.017
  32. Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol. 2003 Jun; 121(6):785-92.
    View in: PubMed
    Score: 0.016
  33. Snow KK, Cote J, Yang W, Davis NJ, Seddon JM. Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women. Am J Ophthalmol. 2002 Dec; 134(6):842-8.
    View in: PubMed
    Score: 0.016
  34. Bernstein PS, Leppert M, Singh N, Dean M, Lewis RA, Lupski JR, Allikmets R, Seddon JM. Genotype-phenotype analysis of ABCR variants in macular degeneration probands and siblings. Invest Ophthalmol Vis Sci. 2002 Feb; 43(2):466-73.
    View in: PubMed
    Score: 0.015
  35. Seddon JM, Afshari MA, Sharma S, Bernstein PS, Chong S, Hutchinson A, Petrukhin K, Allikmets R. Assessment of mutations in the Best macular dystrophy (VMD2) gene in patients with adult-onset foveomacular vitelliform dystrophy, age-related maculopathy, and bull's-eye maculopathy. Ophthalmology. 2001 Nov; 108(11):2060-7.
    View in: PubMed
    Score: 0.015
  36. Seddon JM, Rosner B, Sperduto RD, Yannuzzi L, Haller JA, Blair NP, Willett W. Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol. 2001 Aug; 119(8):1191-9.
    View in: PubMed
    Score: 0.014
  37. Kleinerman RA, Schonfeld SJ, Abramson DH, Francis JH, Seddon JM, Morton LM, Tucker MA. Increased Risk of Skin Cancer in 1,851 Long-Term Retinoblastoma Survivors. J Invest Dermatol. 2021 12; 141(12):2849-2857.e3.
    View in: PubMed
    Score: 0.014
  38. Schonfeld SJ, Kleinerman RA, Abramson DH, Seddon JM, Tucker MA, Morton LM. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors. Br J Cancer. 2021 03; 124(7):1312-1319.
    View in: PubMed
    Score: 0.014
  39. McCabe P, Nason F, Demers Turco P, Friedman D, Seddon JM. Evaluating the effectiveness of a vision rehabilitation intervention using an objective and subjective measure of functional performance. Ophthalmic Epidemiol. 2000 Dec; 7(4):259-70.
    View in: PubMed
    Score: 0.014
  40. Snow KK, Seddon JM. Age-related eye diseases: impact of hormone replacement therapy, and reproductive and other risk factors. Int J Fertil Womens Med. 2000 Sep-Oct; 45(5):301-13.
    View in: PubMed
    Score: 0.014
  41. Cho E, Hankinson SE, Willett WC, Stampfer MJ, Spiegelman D, Speizer FE, Rimm EB, Seddon JM. Prospective study of alcohol consumption and the risk of age-related macular degeneration. Arch Ophthalmol. 2000 May; 118(5):681-8.
    View in: PubMed
    Score: 0.013
  42. Kleinerman RA, Schonfeld SJ, Sigel BS, Wong-Siegel JR, Gilbert ES, Abramson DH, Seddon JM, Tucker MA, Morton LM. Bone and Soft-Tissue Sarcoma Risk in Long-Term Survivors of Hereditary Retinoblastoma Treated With Radiation. J Clin Oncol. 2019 12 10; 37(35):3436-3445.
    View in: PubMed
    Score: 0.013
  43. De la Paz MA, Pericak-Vance MA, Haines JL, Seddon JM. Phenotypic heterogeneity in families with age-related macular degeneration. Am J Ophthalmol. 1997 Sep; 124(3):331-43.
    View in: PubMed
    Score: 0.011
  44. Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am J Ophthalmol. 1997 Feb; 123(2):199-206.
    View in: PubMed
    Score: 0.011
  45. Seddon JM, Willett WC, Speizer FE, Hankinson SE. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA. 1996 Oct 09; 276(14):1141-6.
    View in: PubMed
    Score: 0.010
  46. Kang JH, Wu J, Cho E, Ogata S, Jacques P, Taylor A, Chiu CJ, Wiggs JL, Seddon JM, Hankinson SE, Schaumberg DA, Pasquale LR. Contribution of the Nurses' Health Study to the Epidemiology of Cataract, Age-Related Macular Degeneration, and Glaucoma. Am J Public Health. 2016 Sep; 106(9):1684-9.
    View in: PubMed
    Score: 0.010
  47. Bhutto IA, McLeod DS, Jing T, Sunness JS, Seddon JM, Lutty GA. Increased choroidal mast cells and their degranulation in age-related macular degeneration. Br J Ophthalmol. 2016 May; 100(5):720-6.
    View in: PubMed
    Score: 0.010
  48. de Carlo TE, Adhi M, Salz DA, Joseph T, Waheed NK, Seddon JM, Duker JS, Reichel E. Analysis of Choroidal and Retinal Vasculature in Inherited Retinal Degenerations Using Optical Coherence Tomography Angiography. Ophthalmic Surg Lasers Imaging Retina. 2016 Feb; 47(2):120-7.
    View in: PubMed
    Score: 0.010
  49. Bernstein PS, Seddon JM. Decision-making in the treatment of subfoveal neovascularization in age-related macular degeneration. An analysis from the patient's perspective. Retina. 1996; 16(2):112-6.
    View in: PubMed
    Score: 0.010
  50. Hiller R, Seigel D, Sperduto RD, Blair N, Burton TC, Farber MD, Gragoudas ES, Gunter EW, Haller J, Seddon JM, et al. Serum zinc and serum lipid profiles in 778 adults. Ann Epidemiol. 1995 Nov; 5(6):490-6.
    View in: PubMed
    Score: 0.010
  51. Edwards MM, McLeod DS, Bhutto IA, Villalonga MB, Seddon JM, Lutty GA. Idiopathic preretinal glia in aging and age-related macular degeneration. Exp Eye Res. 2016 09; 150:44-61.
    View in: PubMed
    Score: 0.009
  52. Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA. 1994 Nov 09; 272(18):1413-20.
    View in: PubMed
    Score: 0.009
  53. Seddon JM, Christen WG, Manson JE, LaMotte FS, Glynn RJ, Buring JE, Hennekens CH. The use of vitamin supplements and the risk of cataract among US male physicians. Am J Public Health. 1994 May; 84(5):788-92.
    View in: PubMed
    Score: 0.009
  54. Ajani UA, Willett WC, Seddon JM. Reproducibility of a food frequency questionnaire for use in ocular research. Eye Disease Case-Control Study Group. Invest Ophthalmol Vis Sci. 1994 May; 35(6):2725-33.
    View in: PubMed
    Score: 0.009
  55. Little MP, Schaeffer ML, Reulen RC, Abramson DH, Stovall M, Weathers R, de Vathaire F, Diallo I, Seddon JM, Hawkins MM, Tucker MA, Kleinerman RA. Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US-UK study. Br J Cancer. 2014 May 13; 110(10):2623-32.
    View in: PubMed
    Score: 0.009
  56. Gragoudas ES, Egan KM, Saornil MA, Walsh SM, Albert DM, Seddon JM. The time course of irradiation changes in proton beam-treated uveal melanomas. Ophthalmology. 1993 Oct; 100(10):1555-9; discussion 1560.
    View in: PubMed
    Score: 0.008
  57. Weinberg DV, Egan KM, Seddon JM. Asymmetric distribution of arteriovenous crossings in the normal retina. Ophthalmology. 1993 Jan; 100(1):31-6.
    View in: PubMed
    Score: 0.008
  58. Seddon JM, Egan KM, Zhang Y, Gelles EJ, Glynn RJ, Tucker CA, Gragoudas ES. Evaluation of skin microtopography as a measure of ultraviolet exposure. Invest Ophthalmol Vis Sci. 1992 May; 33(6):1903-8.
    View in: PubMed
    Score: 0.008
  59. Kleinerman RA, Yu CL, Little MP, Li Y, Abramson D, Seddon J, Tucker MA. Variation of second cancer risk by family history of retinoblastoma among long-term survivors. J Clin Oncol. 2012 Mar 20; 30(9):950-7.
    View in: PubMed
    Score: 0.007
  60. Stanton CM, Yates JR, den Hollander AI, Seddon JM, Swaroop A, Stambolian D, Fauser S, Hoyng C, Yu Y, Atsuhiro K, Branham K, Othman M, Chen W, Kortvely E, Chalmers K, Hayward C, Moore AT, Dhillon B, Ueffing M, Wright AF. Complement factor D in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011 Nov 11; 52(12):8828-34.
    View in: PubMed
    Score: 0.007
  61. Francis JH, Kleinerman RA, Seddon JM, Abramson DH. Increased risk of secondary uterine leiomyosarcoma in hereditary retinoblastoma. Gynecol Oncol. 2012 Feb; 124(2):254-9.
    View in: PubMed
    Score: 0.007
  62. McKay GJ, Silvestri G, Chakravarthy U, Dasari S, Fritsche LG, Weber BH, Keilhauer CN, Klein ML, Francis PJ, Klaver CC, Vingerling JR, Ho L, De Jong PT, Dean M, Sawitzke J, Baird PN, Guymer RH, Stambolian D, Orlin A, Seddon JM, Peter I, Wright AF, Hayward C, Lotery AJ, Ennis S, Gorin MB, Weeks DE, Kuo CL, Hingorani AD, Sofat R, Cipriani V, Swaroop A, Othman M, Kanda A, Chen W, Abecasis GR, Yates JR, Webster AR, Moore AT, Seland JH, Rahu M, Soubrane G, Tomazzoli L, Topouzis F, Vioque J, Young IS, Fletcher AE, Patterson CC. Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people. Am J Epidemiol. 2011 Jun 15; 173(12):1357-64.
    View in: PubMed
    Score: 0.007
  63. Seddon JM, Christen WG, Manson JE, Buring JE, Sperduto RD, Hennekens CH. Low-dose aspirin and risks of cataract in a randomized trial of US physicians. Arch Ophthalmol. 1991 Feb; 109(2):252-5.
    View in: PubMed
    Score: 0.007
  64. Seddon JM, Gragoudas ES, Glynn RJ, Egan KM, Albert DM, Blitzer PH. Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol. 1990 Sep; 108(9):1274-80.
    View in: PubMed
    Score: 0.007
  65. Raychaudhuri S, Ripke S, Li M, Neale BM, Fagerness J, Reynolds R, Sobrin L, Swaroop A, Abecasis G, Seddon JM, Daly MJ. Associations of CFHR1-CFHR3 deletion and a CFH SNP to age-related macular degeneration are not independent. Nat Genet. 2010 Jul; 42(7):553-5; author reply 555-6.
    View in: PubMed
    Score: 0.007
  66. Seddon JM, Gragoudas ES, Egan KM, Glynn RJ, Howard S, Fante RG, Albert DM. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology. 1990 Jun; 97(6):769-77.
    View in: PubMed
    Score: 0.007
  67. Smith EV, Kolodny NH, Gragoudas ES, Egan KM, Finn S, D'Amico DJ, Seddon JM. An NMR blood test for uveal melanoma? Invest Ophthalmol Vis Sci. 1990 May; 31(5):993-7.
    View in: PubMed
    Score: 0.007
  68. Chodick G, Kleinerman RA, Stovall M, Abramson DH, Seddon JM, Smith SA, Tucker MA. Risk of cataract extraction among adult retinoblastoma survivors. Arch Ophthalmol. 2009 Nov; 127(11):1500-4.
    View in: PubMed
    Score: 0.006
  69. Zerbib J, Seddon JM, Richard F, Reynolds R, Leveziel N, Benlian P, Borel P, Feingold J, Munnich A, Soubrane G, Kaplan J, Rozet JM, Souied EH. rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration. PLoS One. 2009 Oct 05; 4(10):e7341.
    View in: PubMed
    Score: 0.006
  70. Yu CL, Tucker MA, Abramson DH, Furukawa K, Seddon JM, Stovall M, Fraumeni JF, Kleinerman RA. Cause-specific mortality in long-term survivors of retinoblastoma. J Natl Cancer Inst. 2009 Apr 15; 101(8):581-91.
    View in: PubMed
    Score: 0.006
  71. Friedman E, Ivry M, Ebert E, Glynn R, Gragoudas E, Seddon J. Increased scleral rigidity and age-related macular degeneration. Ophthalmology. 1989 Jan; 96(1):104-8.
    View in: PubMed
    Score: 0.006
  72. Sheen V, Tucker MA, Abramson DH, Seddon JM, Kleinerman RA. Cancer screening practices of adult survivors of retinoblastoma at risk of second cancers. Cancer. 2008 Jul 15; 113(2):434-41.
    View in: PubMed
    Score: 0.006
  73. Maki J, Kusakul S, Morley K, Sanguansak T, Seddon J, Hartung L, Morley M. The effect of glasses on visual function following cataract surgery in a cataract camp. Br J Ophthalmol. 2008 Jul; 92(7):883-7.
    View in: PubMed
    Score: 0.006
  74. SanGiovanni JP, Chew EY, Clemons TE, Ferris FL, Gensler G, Lindblad AS, Milton RC, Seddon JM, Sperduto RD. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol. 2007 Sep; 125(9):1225-32.
    View in: PubMed
    Score: 0.005
  75. Seddon JM, Polivogianis L, Hsieh CC, Albert DM, Gamel JW, Gragoudas ES. Death from uveal melanoma. Number of epithelioid cells and inverse SD of nucleolar area as prognostic factors. Arch Ophthalmol. 1987 Jun; 105(6):801-6.
    View in: PubMed
    Score: 0.005
  76. SanGiovanni JP, Chew EY, Clemons TE, Davis MD, Ferris FL, Gensler GR, Kurinij N, Lindblad AS, Milton RC, Seddon JM, Sperduto RD. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol. 2007 May; 125(5):671-9.
    View in: PubMed
    Score: 0.005
  77. Seddon JM, Gragoudas ES, Egan KM, Glynn RJ, Munzenrider JE, Austin-Seymour M, Goitein M, Verhey L, Urie M, Koehler A. Uveal melanomas near the optic disc or fovea. Visual results after proton beam irradiation. Ophthalmology. 1987 Apr; 94(4):354-61.
    View in: PubMed
    Score: 0.005
  78. Klein R, Deng Y, Klein BE, Hyman L, Seddon J, Frank RN, Wallace RB, Hendrix SL, Kuppermann BD, Langer RD, Kuller L, Brunner R, Johnson KC, Thomas AM, Haan M. Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study. Am J Ophthalmol. 2007 Mar; 143(3):473-83.
    View in: PubMed
    Score: 0.005
  79. Kleinerman RA, Tucker MA, Abramson DH, Seddon JM, Tarone RE, Fraumeni JF. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst. 2007 Jan 03; 99(1):24-31.
    View in: PubMed
    Score: 0.005
  80. Foster MC, Kleinerman RA, Abramson DH, Seddon JM, Tarone RE, Tucker MA. Tobacco use in adult long-term survivors of retinoblastoma. Cancer Epidemiol Biomarkers Prev. 2006 Aug; 15(8):1464-8.
    View in: PubMed
    Score: 0.005
  81. Seddon JM, Gragoudas ES, Polivogianis L, Hsieh CC, Egan KM, Goitein M, Verhey L, Munzenrider J, Austin-Seymour M, Urie M, et al. Visual outcome after proton beam irradiation of uveal melanoma. Ophthalmology. 1986 May; 93(5):666-74.
    View in: PubMed
    Score: 0.005
  82. Seddon JM, Polivogianis L, Gragoudas ES, Hsieh CC, Egan KM. Enucleation vs cobalt 60 irradiation of melanomas. Arch Ophthalmol. 1986 Feb; 104(2):175-6.
    View in: PubMed
    Score: 0.005
  83. Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology. 2005 Apr; 112(4):533-9.
    View in: PubMed
    Score: 0.005
  84. Seddon JM, Gragoudas ES, Albert DM, Hsieh CC, Polivogianis L, Friedenberg GR. Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation. Am J Ophthalmol. 1985 Mar 15; 99(3):282-90.
    View in: PubMed
    Score: 0.005
  85. Austin-Seymour M, Munzenrider JE, Goitein M, Gentry R, Gragoudas E, Koehler AM, McNulty P, Osborne E, Ryugo DK, Seddon J, et al. Progress in low-LET heavy particle therapy: intracranial and paracranial tumors and uveal melanomas. Radiat Res Suppl. 1985; 8:S219-26.
    View in: PubMed
    Score: 0.005
  86. Schaumberg DA, Liu S, Seddon JM, Willett WC, Hankinson SE. Dietary glycemic load and risk of age-related cataract. Am J Clin Nutr. 2004 Aug; 80(2):489-95.
    View in: PubMed
    Score: 0.004
  87. Cho E, Seddon JM, Rosner B, Willett WC, Hankinson SE. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol. 2004 Jun; 122(6):883-92.
    View in: PubMed
    Score: 0.004
  88. Fournier GA, Albert DM, Arrigg CA, Cohen AM, Lamping KA, Seddon JM. Resection of solitary metastasis. Approach to palliative treatment of hepatic involvement with choroidal melanoma. Arch Ophthalmol. 1984 Jan; 102(1):80-2.
    View in: PubMed
    Score: 0.004
  89. Lavin PT, Albert DM, Seddon JM. A deficit survival analysis to assess the natural history of uveal melanoma. J Chronic Dis. 1984; 37(6):481-7.
    View in: PubMed
    Score: 0.004
  90. Seddon JM, Albert DM, Lavin PT, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol. 1983 Dec; 101(12):1894-9.
    View in: PubMed
    Score: 0.004
  91. Bressler NM, Bressler SB, Congdon NG, Ferris FL, Friedman DS, Klein R, Lindblad AS, Milton RC, Seddon JM. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol. 2003 Nov; 121(11):1621-4.
    View in: PubMed
    Score: 0.004
  92. Seddon JM, Gragoudas ES, Albert DM. Ciliary body and choroidal melanomas treated by proton beam irradiation. Histopathologic study of eyes. Arch Ophthalmol. 1983 Sep; 101(9):1402-8.
    View in: PubMed
    Score: 0.004
  93. Seddon JM, Schwartz B, Flowerdew G. Case-control study of ocular hypertension. Arch Ophthalmol. 1983 Jun; 101(6):891-4.
    View in: PubMed
    Score: 0.004
  94. Weintraub JM, Willett WC, Rosner B, Colditz GA, Seddon JM, Hankinson SE. A prospective study of the relationship between body mass index and cataract extraction among US women and men. Int J Obes Relat Metab Disord. 2002 Dec; 26(12):1588-95.
    View in: PubMed
    Score: 0.004
  95. Seddon JM, Corwin JM, Weiter JJ, Brisbane JU, Sutula FC. Solitary extramedullary plasmacytoma of the palpebral conjunctiva. Br J Ophthalmol. 1982 Jul; 66(7):450-4.
    View in: PubMed
    Score: 0.004
  96. Weintraub JM, Willett WC, Rosner B, Colditz GA, Seddon JM, Hankinson SE. Smoking cessation and risk of cataract extraction among US women and men. Am J Epidemiol. 2002 Jan 01; 155(1):72-9.
    View in: PubMed
    Score: 0.004
  97. Ayyagari R, Zhang K, Hutchinson A, Yu Z, Swaroop A, Kakuk LE, Seddon JM, Bernstein PS, Lewis RA, Tammur J, Yang Z, Li Y, Zhang H, Yashar BM, Liu J, Petrukhin K, Sieving PA, Allikmets R. Evaluation of the ELOVL4 gene in patients with age-related macular degeneration. Ophthalmic Genet. 2001 Dec; 22(4):233-9.
    View in: PubMed
    Score: 0.004
  98. Schwartz B, Seddon JM. Increased plasma cortisol levels in ocular hypertension. Arch Ophthalmol. 1981 Oct; 99(10):1791-4.
    View in: PubMed
    Score: 0.004
  99. Cho E, Stampfer MJ, Seddon JM, Hung S, Spiegelman D, Rimm EB, Willett WC, Hankinson SE. Prospective study of zinc intake and the risk of age-related macular degeneration. Ann Epidemiol. 2001 Jul; 11(5):328-36.
    View in: PubMed
    Score: 0.004
  100. Cho E, Hung S, Willett WC, Spiegelman D, Rimm EB, Seddon JM, Colditz GA, Hankinson SE. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr. 2001 Feb; 73(2):209-18.
    View in: PubMed
    Score: 0.003
  101. Kleinerman RA, Tarone RE, Abramson DH, Seddon JM, Li FP, Tucker MA. Hereditary retinoblastoma and risk of lung cancer. J Natl Cancer Inst. 2000 Dec 20; 92(24):2037-9.
    View in: PubMed
    Score: 0.003
  102. Chasan-Taber L, Willett WC, Seddon JM, Stampfer MJ, Rosner B, Colditz GA, Speizer FE, Hankinson SE. A prospective study of alcohol consumption and cataract extraction among U.S. women. Ann Epidemiol. 2000 Aug; 10(6):347-53.
    View in: PubMed
    Score: 0.003
  103. Li W, Judge H, Gragoudas ES, Seddon JM, Egan KM. Patterns of tumor initiation in choroidal melanoma. Cancer Res. 2000 Jul 15; 60(14):3757-60.
    View in: PubMed
    Score: 0.003
  104. Gragoudas ES, Lane AM, Regan S, Li W, Judge HE, Munzenrider JE, Seddon JM, Egan KM. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol. 2000 Jun; 118(6):773-8.
    View in: PubMed
    Score: 0.003
  105. Chasan-Taber L, Willett WC, Seddon JM, Stampfer MJ, Rosner B, Colditz GA, Hankinson SE. A prospective study of vitamin supplement intake and cataract extraction among U.S. women. Epidemiology. 1999 Nov; 10(6):679-84.
    View in: PubMed
    Score: 0.003
  106. Chasan-Taber L, Willett WC, Seddon JM, Stampfer MJ, Rosner B, Colditz GA, Speizer FE, Hankinson SE. A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women. Am J Clin Nutr. 1999 Oct; 70(4):509-16.
    View in: PubMed
    Score: 0.003
  107. Brown L, Rimm EB, Seddon JM, Giovannucci EL, Chasan-Taber L, Spiegelman D, Willett WC, Hankinson SE. A prospective study of carotenoid intake and risk of cataract extraction in US men. Am J Clin Nutr. 1999 Oct; 70(4):517-24.
    View in: PubMed
    Score: 0.003
  108. Chew EY, Sperduto RD, Hiller R, Nowroozi L, Seigel D, Yanuzzi LA, Burton TC, Seddon JM, Gragoudas ES, Haller JA, Blair NP, Farber M. Clinical course of macular holes: the Eye Disease Case-Control Study. Arch Ophthalmol. 1999 Feb; 117(2):242-6.
    View in: PubMed
    Score: 0.003
  109. Sperduto RD, Hiller R, Chew E, Seigel D, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Seddon JM, Yannuzzi LA. Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study. Ophthalmology. 1998 May; 105(5):765-71.
    View in: PubMed
    Score: 0.003
  110. Wong FL, Boice JD, Abramson DH, Tarone RE, Kleinerman RA, Stovall M, Goldman MB, Seddon JM, Tarbell N, Fraumeni JF, Li FP. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA. 1997 Oct 15; 278(15):1262-7.
    View in: PubMed
    Score: 0.003
  111. Allikmets R, Shroyer NF, Singh N, Seddon JM, Lewis RA, Bernstein PS, Peiffer A, Zabriskie NA, Li Y, Hutchinson A, Dean M, Lupski JR, Leppert M. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science. 1997 Sep 19; 277(5333):1805-7.
    View in: PubMed
    Score: 0.003
  112. Christen WG, Glynn RJ, Seddon JM, Manson JE, Buring JE, Hennekens CH. Confirmation of self-reported cataract in the Physicians' Health Study. Ophthalmic Epidemiol. 1994 Jun; 1(2):85-91.
    View in: PubMed
    Score: 0.002
  113. Manson JE, Christen WG, Seddon JM, Glynn RJ, Hennekens CH. A prospective study of alcohol consumption and risk of cataract. Am J Prev Med. 1994 May-Jun; 10(3):156-61.
    View in: PubMed
    Score: 0.002
  114. Egan KM, Walsh SM, Seddon JM, Gragoudas ES. An evaluation of the influence of reproductive factors on the risk of metastases from uveal melanoma. Ophthalmology. 1993 Aug; 100(8):1160-5; discussion 1166.
    View in: PubMed
    Score: 0.002
  115. Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, Seddon J, Tarbell N, Boice JD. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst. 1993 Jul 21; 85(14):1121-8.
    View in: PubMed
    Score: 0.002
  116. Mangione CM, Seddon JM, Cook EF, Krug JH, Sahagian CR, Campion EW, Glynn RJ. Correlates of cognitive function scores in elderly outpatients. J Am Geriatr Soc. 1993 May; 41(5):491-7.
    View in: PubMed
    Score: 0.002
  117. Hankinson SE, Seddon JM, Colditz GA, Stampfer MJ, Rosner B, Speizer FE, Willett WC. A prospective study of aspirin use and cataract extraction in women. Arch Ophthalmol. 1993 Apr; 111(4):503-8.
    View in: PubMed
    Score: 0.002
  118. Ajani UA, Seddon JM, Hsieh CC, Egan KM, Albert DM, Gragoudas ES. Occupation and risk of uveal melanoma. An exploratory study. Cancer. 1992 Dec 15; 70(12):2891-900.
    View in: PubMed
    Score: 0.002
  119. Christen WG, Manson JE, Seddon JM, Glynn RJ, Buring JE, Rosner B, Hennekens CH. A prospective study of cigarette smoking and risk of cataract in men. JAMA. 1992 Aug 26; 268(8):989-93.
    View in: PubMed
    Score: 0.002
  120. Hankinson SE, Willett WC, Colditz GA, Seddon JM, Rosner B, Speizer FE, Stampfer MJ. A prospective study of cigarette smoking and risk of cataract surgery in women. JAMA. 1992 Aug 26; 268(8):994-8.
    View in: PubMed
    Score: 0.002
  121. Hankinson SE, Stampfer MJ, Seddon JM, Colditz GA, Rosner B, Speizer FE, Willett WC. Nutrient intake and cataract extraction in women: a prospective study. BMJ. 1992 Aug 08; 305(6849):335-9.
    View in: PubMed
    Score: 0.002
  122. Saornil MA, Egan KM, Gragoudas ES, Seddon JM, Walsh SM, Albert DM. Histopathology of proton beam-irradiated vs enucleated uveal melanomas. Arch Ophthalmol. 1992 Aug; 110(8):1112-8.
    View in: PubMed
    Score: 0.002
  123. Guyer DR, Mukai S, Egan KM, Seddon JM, Walsh SM, Gragoudas ES. Radiation maculopathy after proton beam irradiation for choroidal melanoma. Ophthalmology. 1992 Aug; 99(8):1278-85.
    View in: PubMed
    Score: 0.002
  124. Gragoudas ES, Egan KM, Seddon JM, Walsh SM, Munzenrider JE. Intraocular recurrence of uveal melanoma after proton beam irradiation. Ophthalmology. 1992 May; 99(5):760-6.
    View in: PubMed
    Score: 0.002
  125. Gragoudas ES, Egan KM, Arrigg PG, Seddon JM, Glynn RJ, Munzenrider JE. Cataract extraction after proton beam irradiation for malignant melanoma of the eye. Arch Ophthalmol. 1992 Apr; 110(4):475-9.
    View in: PubMed
    Score: 0.002
  126. Egan KM, Gragoudas ES, Seddon JM, Walsh SM. Smoking and the risk of early metastases from uveal melanoma. Ophthalmology. 1992 Apr; 99(4):537-41.
    View in: PubMed
    Score: 0.002
  127. Gragoudas ES, Egan KM, Seddon JM, Glynn RJ, Walsh SM, Finn SM, Munzenrider JE, Spar MD. Survival of patients with metastases from uveal melanoma. Ophthalmology. 1991 Mar; 98(3):383-9; discussion 390.
    View in: PubMed
    Score: 0.002
  128. Glynn RJ, Schein OD, Seddon JM, Poggio EC, Goodfellow JR, Scardino VA, Shannon MJ, Kenyon KR. The incidence of ulcerative keratitis among aphakic contact lens wearers in New England. Arch Ophthalmol. 1991 Jan; 109(1):104-7.
    View in: PubMed
    Score: 0.002
  129. Austin KL, Palmer JR, Seddon JM, Glynn RJ, Rosenberg L, Gragoudas ES, Kaufman DW, Shapiro S. Case-control study of idiopathic retinal detachment. Int J Epidemiol. 1990 Dec; 19(4):1045-50.
    View in: PubMed
    Score: 0.002
  130. Lischko AM, Seddon JM, Gragoudas ES, Egan KM, Glynn RJ. Evaluation of prior primary malignancy as a determinant of uveal melanoma. A case-control study. Ophthalmology. 1989 Dec; 96(12):1716-21.
    View in: PubMed
    Score: 0.002
  131. Munzenrider JE, Verhey LJ, Gragoudas ES, Seddon JM, Urie M, Gentry R, Birnbaum S, Ruotolo DM, Crowell C, McManus P, et al. Conservative treatment of uveal melanoma: local recurrence after proton beam therapy. Int J Radiat Oncol Biol Phys. 1989 Sep; 17(3):493-8.
    View in: PubMed
    Score: 0.002
  132. Egan KM, Gragoudas ES, Seddon JM, Glynn RJ, Munzenreider JE, Goitein M, Verhey L, Urie M, Koehler A. The risk of enucleation after proton beam irradiation of uveal melanoma. Ophthalmology. 1989 Sep; 96(9):1377-82; discussion 1382-3.
    View in: PubMed
    Score: 0.002
  133. Gragoudas ES, Seddon JM, Egan KM, Glynn RJ, Goitein M, Munzenrider J, Verhey L, Urie M, Koehler A. Metastasis from uveal melanoma after proton beam irradiation. Ophthalmology. 1988 Jul; 95(7):992-9.
    View in: PubMed
    Score: 0.001
  134. Adams KS, Abramson DH, Ellsworth RM, Haik BG, Bedford M, Packer S, Seddon J, Albert D, Polivogianis L. Cobalt plaque versus enucleation for uveal melanoma: comparison of survival rates. Br J Ophthalmol. 1988 Jul; 72(7):494-7.
    View in: PubMed
    Score: 0.001
  135. Glynn RJ, Seddon JM, Berlin BM. The incidence of eye injuries in New England adults. Arch Ophthalmol. 1988 Jun; 106(6):785-9.
    View in: PubMed
    Score: 0.001
  136. Schein OD, Hibberd PL, Shingleton BJ, Kunzweiler T, Frambach DA, Seddon JM, Fontan NL, Vinger PF. The spectrum and burden of ocular injury. Ophthalmology. 1988 Mar; 95(3):300-5.
    View in: PubMed
    Score: 0.001
  137. Bressler NM, Bressler SB, Seddon JM, Gragoudas ES, Jacobson LP. Drusen characteristics in patients with exudative versus non-exudative age-related macular degeneration. Retina. 1988; 8(2):109-14.
    View in: PubMed
    Score: 0.001
  138. terPenning BJ, Cheng HM, Barnett P, Seddon J, Sang D, Latina M, Aguayo J, Gonz?lez RG, Brady TJ. MR imaging of enucleated human eyes at 1.4 tesla. J Comput Assist Tomogr. 1986 Jul-Aug; 10(4):551-9.
    View in: PubMed
    Score: 0.001
  139. Gragoudas ES, Seddon JM, Egan KM, Polivogianis L, Hsieh CC, Goitein M, Verhey L, Munzenrider J, Austin-Seymour M, Urie M, et al. Prognostic factors for metastasis following proton beam irradiation of uveal melanomas. Ophthalmology. 1986 May; 93(5):675-80.
    View in: PubMed
    Score: 0.001
  140. Weinhaus RS, Seddon JM, Albert DM, Gragoudas ES, Robinson N. Prognostic factor study of survival after enucleation for juxtapapillary melanomas. Arch Ophthalmol. 1985 Nov; 103(11):1673-7.
    View in: PubMed
    Score: 0.001
  141. Gragoudas ES, Seddon J, Goitein M, Verhey L, Munzenrider J, Urie M, Suit HD, Blitzer P, Koehler A. Current results of proton beam irradiation of uveal melanomas. Ophthalmology. 1985 Feb; 92(2):284-91.
    View in: PubMed
    Score: 0.001
  142. Gragoudas ES, Goitein M, Seddon J, Verhey L, Munzenrider J, Urie M, Suit HD, Blitzer P, Johnson KN, Koehler A. Preliminary results of proton beam irradiation of macular and paramacular melanomas. Br J Ophthalmol. 1984 Jul; 68(7):479-85.
    View in: PubMed
    Score: 0.001
  143. Albert DM, McGhee CN, Seddon JM, Weichselbaum RR. Development of additional primary tumors after 62 years in the first patient with retinoblastoma cured by radiation therapy. Am J Ophthalmol. 1984 Feb; 97(2):189-96.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.